# Memantine for Spasticity in MS Patients

> **NCT00638027** · PHASE4 · COMPLETED · sponsor: **University of Rochester** · enrollment: 21 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** placebo
- **DRUG:** memantine

## Key facts

- **NCT ID:** NCT00638027
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638027, "Memantine for Spasticity in MS Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00638027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*